Scrip is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Nanjing Medical Company To Restructure Xinjiang Production and Construction Corps Pharmaceutical

This article was originally published in PharmAsia News

Executive Summary

Nanjing Medical Company has signed an agreement to take a controlling stake in Xinjiang Production and Construction Corps Pharmaceutical. Under the agreement, Nanjing Medical will introduce funds, talent, products, an innovative business model and a modern management model to the Xinjiang company. On its part, the Xinjiang company will incorporate its TCM business and ethnic medicine resources with Nanjing Medical's TCM brand, farming base and end-user market. With sales exceeding RMB 3 billion, Xinjiang Production is a key state-owned pharmaceutical distributor as well as a national medical reserve unit for disaster relief. Nanjing Medical's core revenue hit RMB 8.152 billion in the first half of 2008, with its external expansion model accounting for the rapid growth. (Click here for more - Chinese language)



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts